Compare · BAM vs EVH
BAM vs EVH
Side-by-side comparison of Brookfield Asset Management Inc (BAM) and Evolent Health Inc (EVH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BAM and EVH operate in Other Consumer Services (Consumer Discretionary), so they compete in similar markets.
- BAM is the larger of the two at $79.17B, about 121.2x EVH ($653.5M).
- Over the past year, BAM is down 20.5% and EVH is down 39.0% - BAM leads by 18.6 points.
- EVH has been more active in the news (6 items in the past 4 weeks vs 4 for BAM).
- BAM has more recent analyst coverage (25 ratings vs 20 for EVH).
- Company
- Brookfield Asset Management Inc
- Evolent Health Inc
- Price
- $48.33-2.49%
- $5.81+2.47%
- Market cap
- $79.17B
- $653.5M
- 1M return
- -0.55%
- +23.35%
- 1Y return
- -20.48%
- -39.03%
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NYSE
- NYSE
- IPO
- 2022
- 2015
- News (4w)
- 4
- 6
- Recent ratings
- 25
- 20
Brookfield Asset Management Inc
Brookfield Asset Management is a leading global alternative asset manager and one of the largest investors in real assets. Our investment focus is on real estate, renewable power, infrastructure and private equity assets. Our objective is to generate attractive long-term risk-adjusted returns for the benefit of our clients and shareholders. We manage a range of public and private investment products and services for institutional and retail clients. We earn asset management income for doing so and align our interests with our clients by investing alongside them. We have an exceptionally strong balance sheet, with over $30 billion of capital invested, primarily in our four listed partnerships: Brookfield Property Partners, Brookfield Infrastructure Partners, Brookfield Renewable Partners and Brookfield Business Partners. This access to large-scale capital enables us to make investments in sizeable, premier assets across geographies and asset classes that few managers are able to do. We create value for BAM shareholders in the following ways: As an asset manager  by investing both our own capital and that of our investors  this enables us to increase the scale of our operations, and enhances our financial returns through base management fees and performance-based income; as an investor and capital allocator  we strive to invest at attractive valuations, particularly in value-oriented situations that create opportunities for superior valuation gains and cash flow returns, or by monetizing assets at appropriate times to realize value; and as an owner-operator  we constantly work to increase the value of the assets within our operating businesses and the cash flows they produce through our operating expertise, development capabilities and effective financing.
Evolent Health Inc
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Latest BAM
- Brookfield Asset Management Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Brookfield Asset Management to Host Second Quarter 2026 Results Conference Call
- Brookfield Asset Management Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- The U.S. Department of Energy Announces Conditional $17.5 billion Financing to Support Westinghouse Nuclear Reactor Deployment
- Scout Clean Energy Moves into New Ottawa Office and Celebrates Trail Road BESS Construction Start
- Brookfield Asset Management Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Mitsubishi HC Capital and Brookfield Partner to Launch Renewable Energy Company
- Sunflower Bank Closes Sale of Approximately $890 Million of Multifamily Commercial Real Estate Loans to Brookfield
- Concert Properties and Brookfield Form Joint Venture for Canadian Industrial Portfolio
- AllianceBernstein, Brookfield, and Carlyle Unveil Turnkey Private-Markets Solution for Defined Contribution Plans
Latest EVH
- Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026
- Chief Executive Officer Blackley Seth was granted 446,102 shares and covered exercise/tax liability with 10,297 shares, increasing direct ownership by 52% to 1,272,767 units (SEC Form 4) (tax liability)
- General Counsel Weinberg Jonathan was granted 43,055 shares and covered exercise/tax liability with 2,650 shares, increasing direct ownership by 17% to 284,917 units (SEC Form 4) to satisfy tax liability
- PRESIDENT Mccarthy Daniel Joseph was granted 302,585 shares and covered exercise/tax liability with 4,582 shares, increasing direct ownership by 70% to 721,025 units (SEC Form 4) to cover withholding tax
- Chief Accounting Officer Shams Aammaad was granted 28,790 shares, increasing direct ownership by 43% to 95,637 units (SEC Form 4)
- Evolent Health downgraded by Truist with a new price target
- SEC Form S-8 filed by Evolent Health Inc
- Director Ajayi Toyin was granted 41,096 shares, increasing direct ownership by 121% to 75,170 units (SEC Form 4)
- Director Glass Russell Monroe was granted 41,096 shares, increasing direct ownership by 113% to 77,347 units (SEC Form 4)
- Director Grua Peter J was granted 41,096 shares, increasing direct ownership by 187% to 63,075 units (SEC Form 4)